Zur Navigation springenZum Content springenLogin | Aktuelles | Impressum | Datenschutz
Logo
  • GRK2633
  • People
    • Doctoral researchers
    • Participating researchers
    • Early career researchers
    • Administration
    • RTG Persons of trust
    • Finished doctoral degrees
  • Projects
    • 1st Generation
    • 2nd Generation
  • Events
  • Publications
  • Contacts
GRK2633 | Defining and Targeting Autoimmune Pre-Disease
University of Lübeck - Defining and Targeting Autoimmune Pre-Disease - Projects - 2nd Generation - Concluded projects - Medical doctoral researchers
Medical doctoral researchers
  • Projects
    • 1st Generation
    • 2nd Generation
      • A: Defining Autoimmune Pre-Disease
      • B: Targeting of Autoimmune Pre-Disease
      • Associated projects
      • Medical doctoral researcher projects
      • Concluded projects
        • Medical doctoral researchers
          • MD A20: Molecular and cellular characterization of aging effects in liver and plasma in mice
          • MD A21: Kinase activity profiling of autoantibody-mediated angiotensin II type 1 receptor signaling in endothelial and immune cells
          • MD A22: Systemic lupus erythematosus and fibromyalgia syndrome – movement as a biomarker for pain perception
          • MD B8: Deciphering the signaling events in desmoglein 1 and 3 antibody-induced pathology to investigate possible impacts for the onset of new autoimmune reactions
          • MD B11: Nutritional treatment study to improve inflammatory IgG Fc glycosylation
          • MD B12: Resting heart rate as a prognostic marker for fatigue in primary Sjoegren's syndrome

 

 

RTG 2633
Autoimmune Pre-Disease
University of Lübeck
Spokesperson: Ralf Ludwig